Skip to main content
British Medical Journal logoLink to British Medical Journal
. 1958 Jun 21;1(5085):1452–1454. doi: 10.1136/bmj.1.5085.1452

Clinical Trial of Acepromazine Maleate in Chronic Schizophrenia

Jessie F Collard, Ronald Maggs
PMCID: PMC2029326  PMID: 13536530

Full text

PDF
1452

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BAKER A. A., THORPE J. G. Deteriorated psychotic patients; their treatment and its assessment. J Ment Sci. 1956 Oct;102(429):780–789. doi: 10.1192/bjp.102.429.780. [DOI] [PubMed] [Google Scholar]
  2. BOARDMAN R. H., LOMAS J., MARKOWE M. Insulin and chlorpromazine in schizophrenia; a comparative study in previously untreated cases. Lancet. 1956 Sep 8;271(6941):487–491. doi: 10.1016/s0140-6736(56)91972-9. [DOI] [PubMed] [Google Scholar]
  3. STAFFORD-CLARK D. Discussion on the toxic effect of drugs used in neurological & psychiatric practice. Proc R Soc Med. 1957 Aug;50(8):615–617. [PubMed] [Google Scholar]
  4. WING L. The use of reserpine in chronic psychotic patients: a controlled trial. J Ment Sci. 1956 Jul;102(428):530–541. doi: 10.1192/bjp.102.428.530. [DOI] [PubMed] [Google Scholar]

Articles from British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES